INTRODUCTION 43
In recent years, tropical and subtropical, benthic marine cyanobacteria have attracted 44 much attention due to their extraordinary capacities to produce structurally diverse and 45 highly bioactive secondary metabolites (1, 2, 3, 4) . These bioactive molecules deter 46 grazers and are often potent toxins, and can underlie cyanobacterial harmful algal blooms 47 (CyanoHABs) (5, 6). In marine environments, these toxic CyanoHABs are increasing 48 globally in frequency and size by alarming rates and represent hazards to both human 49 health and natural ecosystems (7, 8) . 50
Despite their toxicity, many cyanobacterial secondary metabolites also have potential 51
for a broad spectrum of pharmaceutical applications, such as anticancer, anti-52 inflammatory, antibacterial and anti-infective applications (1, 2, 4, 9) . In addition, many 53 of these cyanobacterial secondary metabolites also have other potential commercial 54 applications such as insecticides, algaecides and herbicides (10). 55
To date, an impressive 533 natural products (NPs) have been reported from marine 56 strains of cyanobacteria (11). The taxonomic distribution of these NPs is, however, 57 remarkably uneven with over 90% of all of these molecules attributed to only five 58 cyanobacterial genera (11) . Recently, with the inclusion of molecular phylogenetics in 59 cyanobacterial taxonomy, our understanding of biodiversity in this group has drastically 60 increased (12). For example, the NP-rich genus Lyngbya has been shown to be a 61 polyphyletic group and composed of several phylogenetically distant and unrelated 62 lineages (13, 14) , and a wide variety of different molecules attributed to Lyngbya have 63 been isolated from specimens of these different lineages (15 Chimeric gene sequences were predicted using the Pintail software with the cut-off size 135 set at >600 bp (22), and were manually confirmed by comparison of neighbor-joining 136 phylograms for different regions (>300 bp) of the sequences. The unicellular Gloeobacter 137 violaceus PCC 7421 (GenBank acc. Nr. NC005125) was included as an evolutionary 138 distant out-group. Gene sequences were aligned using the MUSCLE algorithm (23). The 139 best-fitting nucleotide substitution models optimized by Maximum Likelihood (ML) 140 were compared and selected using uncorrected/corrected Akaike Information Criterion, 141
Bayesian Information Criterion, and the Decision-theoretic in jModeltest 0.1.1 (24). The 142 evolutionary histories of the cyanobacterial genes were inferred using ML and Bayesian 143 inference algorithms. The ML inference was performed using RaxML with 500 144 bootstrap-replicates (25). Bayesian inference was conducted using MrBayes 3.1 with four 145
Metropolis-coupled MCMC chains (one cold and three heated) run for 1,000,000 146 generations (26). 147
148

RESULTS
149
Natural products diversity. A total of 126 structurally diverse natural products 150 (NPs), isolated from 43 different strains of cyanobacteria, were included in this study 151 (TABLE 1) . This data set of NP-producing cyanobacterial strains included: (i) re-152 collected specimens (n NPs = 26; n strains = 10), (ii) strains available in culture (n NPs = 17; 153 n strains = 6), and (iii) genetically-preserved specimens (n NPs = 6: n strains = 3). In addition, 154 these samples were complemented by gene sequence data for published NP-producing 155 strains available in GenBank (n NPs = 77; n strains = 27) to further broaden the interpretation 156 to represent an individual cyanobacterial genus. Among these ten clades, Clade I (n strains = 168 11; n NPs = 37) and Clade II (n strains = 15; n NPs = 56) were clearly overrepresented in their 169 production of NPs and together contained over 70% of all of these NPs. (FIG. 2) Two 170 other major NP-producing groups were Clade III (n strains = 6; n NPs = 12) and Clade IV 171 (n strains = 4; n NPs = 7). A total of 14 secondary metabolites were isolated from the 172 remaining six clades (Clade V-X). regions. This is primarily due to a lack of proper classification systems since tropical 214 marine cyanobacteria have only recently been investigated taxonomically using 215 phylogenetic methods. As a result, our current perspective of the taxonomic origin and 216 distribution of NPs in marine cyanobacteria is here shown to be incomplete. For example, 217 over 90% of all marine-derived NP's have been attributed to the three cyanobacterial 218 genera Lyngbya, Oscillatoria and Symploca (11). However, none of the NP-producing 219 cyanobacterial strains attributed to these three groups were, in this study, related to their 220 respective reference strains. The common perception of these genera as NP-rich groups 221 can therefore be assumed to be incorrect and the NPs ascribed to these genera are most 222 likely produced by other, often undescribed groups with morphological similarities. necessary to resolve if these NP-rich specimens, in fact, have evolved to be 251 biosynthetically more prolific in bioactive secondary metabolite production. However, 252
arguably such genomic investigations rely on informative taxonomic systems that truly 253 reflect biodiversity. This study is intended to provide an evolutionary framework for such 254 a system. Moreover, the phylogenetic inferences of these NP-producing cyanobacteria 255 uncover true biodiversity, which is essential for monitoring and predicting 256 environmentally important CyanoHABs as well as sustaining efficient and productive 257 bioactive secondary metabolite discovery efforts for pharmaceutical applications. 
